The manufacturer of the attention-deficit/hyperactivity disorder medication Vyvanse is planning to provide the medication in three new dosage strengths. Shire says that 20, 40, and 60 mg doses will be available this spring.
Read moreThe attention-deficit/hyperactivity medication Vyvanse is now available in three additional dosage strengths. Now there are six dosages: 20mg, 30mg,... Read more »
Brand Name: Vyvanse Generic Name: lisdexamfetamine dimesylate Usage: Vyvanse has been approved by the Food and Drug Administration to treat... Read more »
Source: First DataBank
Generic Name: LISDEXAMFETAMINE - ORAL Pronounced: (lis-DEX-am-FET-a-meen) Warning Misuse or abuse of amphetamines may result in serious... Read more »
Vyvanse, the daily medication to treat symptoms of attention-deficit/hyperactivity disorder, is now available in the United States. Vyvanse works... Read more »
Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication.... Read more »